PharmaCyte Biotech CEO Kenneth Waggoner's 2023 pay falls 52% to $441K
PharmaCyte Biotech reports 2023 executive compensation
By ExecPay News
Published: March 27, 2024
PharmaCyte Biotech reported fiscal year 2023 executive compensation information on March 27, 2024.
In 2023, four executives at PharmaCyte Biotech received on average a compensation package of $273K, a 52% decrease compared to previous year.
Average pay of disclosed executives at PharmaCyte Biotech
Kenneth L. Waggoner, Chief Executive Officer, received $441K in total, which decreased by 52% compared to 2022. 98% of Waggoner's compensation, or $433K, was in salary. Waggoner also received $3.9K in option awards and $4K in stock awards.
Carlos A. Trujillo, Chief Financial Officer, received a compensation package of $385K, which decreased by 39% compared to previous year. 99% of the compensation package, or $380K, was in salary.
Joshua N. Silverman, Chief Executive Officer, earned $198K in 2023.
Gerald W. Crabtree, Chief Scientific Officer, received $67K in 2023, which decreases by 51% compared to 2022.
PharmaCyte Biotech's fiscal year ends on April 30.
Related executives
You may also like
Source: SEC filing on March 27, 2024.